@dansfera: Unicure's recent plunge is raising eyebrows across the biotech arena! 📉 After the FDA deemed the data from their AMT-130 trial inadequate—despite claims of a 75% effectiveness in slowing Huntington's disease progression—the future looks uncertain for this gene-editing contender. The lack of randomized clinical trial validation has sparked debate, especially when the alternatives are limited to palliative care. What does this mean for patients and the broader fight against Huntington's? Tune in to catch the latest insights on this unfolding story! #BiotechNews #HuntingtonsDisease #GeneEditing #FDA #Unicure

dansfera

Open In TikTok:

Region: US

Monday 24 November 2025 22:23:33 GMT